Home LamKap Bio Group

LamKap Bio Group

In operation
-
Bispecific Antibody Developer

Basic Information

LamKap Bio Group's core focus is on the research, development, and manufacturing of selected bispecific antibodies for antibody-based therapies targeting cancer and immune system diseases.
LamKap Bio Group
Zurich,Switzerland
15~50 people
January 01, 2017
info@lamkapbio.com